Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Avigan could be formally approved as Ebola drug early 2015

TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus.

E

Avigan could be formally approved as Ebola drug early 2015

TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus. (Kyodo)

E

Japan after coronavirus state-of-emergency lifting

Japanese health minister Katsunobu Kato speaks at a press conference in Tokyo on May 26, 2020, about Fujifilm Holdings Corp's anti-influenza drug Avigan. The government has given up on approving the drug this month for the treatment of coronavirus patients. (Kyodo) ==Kyodo